Fiscella, Michele
Regenxbio (United States)
4 papers on CoChatORCID 0000-0003-3869-9948
Most cited papers
- Verified
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
Pukac, L., Kanakaraj, P., Humphreys, R., Alderson, R., Bloom, M., Sung, C., Riccobene, T., Johnson, R., Fiscella, M., Mahoney, A., et al. (2005) · British Journal of Cancer
Cell death mechanisms and regulationCancer-related Molecular Pathways
Cited by 306
- Verified
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression
Ding, K., Shen, J., Hafiz, Z., Hackett, S. F., Silva, R. L. E., Khan, M., Lorenc, V. E., Chen, D., Chadha, R., Zhang, M., et al. (2019) · Journal of Clinical Investigation
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 141
- Verified
Characterization of AAV-mediated dorsal root ganglionopathy
Buss, N., Lanigan, L., Zeller, J., Cissell, D., Metea, M., Adams, E., Higgins, M., Kim, K. H., Budzynski, E., Yang, L., et al. (2022) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchPain Mechanisms and Treatments
Cited by 81
- Verified
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays
Gorovits, B., Fiscella, M., Havert, M., Koren, E., Long, B., Milton, M., & Purushothama, S. (2020) · The AAPS Journal
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 57
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free